News

Cuatroochenta
_
Reports
_
26%
_
Revenue
_
Growth
_
and
_
70%
_
Increase
_
in
_
EBITDA
_
in
_
Q1
_
2025

BME Growth  ·  Investors  ·  Present

The technology company’s Annual Recurring Revenue (ARR) rose by 14% to €22 million, while its share price reached its highest level on BME Growth since 2022.

Following a record-breaking annual profit, Cuatroochenta has published its consolidated financial statements as of March 31, 2025, on BME Growth, reflecting accelerated growth and improved profitability. The company posted a 26% year-over-year increase in net revenue, reaching €8.2 million in Q1 2025, driven entirely by organic growth.

In the same period, Cuatroochenta’s EBITDA rose by 70%, reaching €1 million. Net profit came in at €0.5 million—nearly tripling the result achieved in the same quarter of 2024.

Similarly, Annual Recurring Revenue (ARR)—revenues generated through subscriptions, renewable contracts, or agreements—stood at €21.9 million, up 14% from €19.35 million as of December 31, 2024.

Highest Share Price Since 2022

The Q1 2025 results follow upward revisions by independent financial analysts covering the company. JB Capital raised its price target for Cuatroochenta shares by 11% in a note published after the release of FY2024 results, citing revenues that exceeded estimates by 22% and reinforcing the company's growth narrative. In May, Cuatroochenta’s stock price consistently traded above €15, reaching its highest level since 2022, and bringing its market capitalization to over €40 million.

0
*Share price as of May 12, 2025

0
*Market capitalization as of May 12, 2025

Cuatroochenta Accelerates Growth and Profitability in Q1 2025, Reaching Its Highest Valuation on BME Growth in Three Years.

Invest in Cuatroochenta